US2009208999A1PendingUtilityA1
Crystalline amoxicillin trihydrate powder
Est. expiryMar 21, 2023(expired)· nominal 20-yr term from priority
A61K 9/14A61K 31/43A61K 9/2054A61K 9/2072
68
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention relates to crystalline amoxicillin trihydrate powder having a bulk density higher than 0.45 g/ml. The invention also relates to a process for preparing crystalline amoxicillin trihydrate powder, said process comprising: crystallizing amoxicillin trihydrate from a solution containing dissolved amoxicillin; separating the crystals from said solution; and drying the separated crystals, resulting in crystalline powder having a bulk density higher than 0.45 g/ml.
Claims
exact text as granted — not AI-modified1 - 20 . (canceled)
21 . Process for preparing crystalline amoxicillin trihydrate powder having a bulk density higher than 0.45 g/ml and a d 50 lower than 100 μm, said process comprising:
resulting in crystalline powder having a bulk density higher than 0.45 g/ml, and a d 50 lower than 100 μm.
22 . Process according to claim 21 , resulting in crystalline powder having a tapped density higher than 0.6 g/ml, wherein said tapped density is determined according to USP 24, method II.
23 . Process according to claim 21 , resulting in crystalline powder having a d 50 higher than 10 μm.
24 . Process according to claim 21 , resulting in crystalline powder having a d 10 higher than 3 μm.
25 . Process according to claim 21 , wherein the process comprises mechanically impacting the crystals during said drying.
26 . Process according to claim 21 , wherein the process comprises:
preparing amoxicillin by reacting 6-amino-penicillanic acid or a salt thereof, with para-hydroxyphenyl glycine in activated form in the presence of an enzyme immobilized on a carrier; forming an aqueous solution containing the amoxicillin, said aqueous solution containing hydrochloric acid; and crystallizing amoxicillin trihydrate from said aqueous solution.
27 . Process according to claim 21 , wherein the aqueous solution from which the amoxicillin is crystallized has an amoxicillin concentration of less than 0.6 mol/l.
28 . Process according to claim 21 , wherein the solution from which the amoxicillin is crystallized contains less than 200 weight parts of protein per 1.000.000 weight parts of the amoxicillin antibiotic in said solution.Join the waitlist — get patent alerts
Track US2009208999A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.